Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;82(4):e11-e12.
doi: 10.1016/j.jinf.2021.01.005. Epub 2021 Jan 13.

Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months

Affiliations
Comment

Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months

Aodhán Seán Breathnach et al. J Infect. 2021 Apr.

Abstract

Image, graphical abstract

PubMed Disclaimer

Conflict of interest statement

Declarations of Competing Interest The authors declare they have no conflicts of interest.

Figures

Image, graphical abstract
Graphical abstract

Comment on

References

    1. Hanrath AT, Payne BAI, Duncan CJA. Prior SARS-CoV-2infection is associated with protection against symptomatic reinfection. J Infect (2020 Dec 23), doi:10.1016/j.jinf.2020.12.023. - DOI - PMC - PubMed
    1. Lumley SF, O'Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med. (2020 Dec 23), doi:10.1056/NEJMoa2034545. Epub ahead of print. PMID: 33369366. - DOI - PMC - PubMed
    1. Sariol A., Perlman S. Lessons for COVID-19 immunity from other coronavirus infections. Immunity. 2020 Aug 18;53(2):248–263. doi: 10.1016/j.immuni.2020.07.005. - DOI - PMC - PubMed
    2. Epub 2020 Jul 14. PMID: 32717182; PMCID: PMC7359787.

    1. Tan Y, Liu F, Xu X, Ling Y, Huang W, Zhu Z, et al. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection. Front Med 2020 Sep 16. [Epub ahead of print] doi:10.1007/s11684-020-0822-5. - DOI - PMC - PubMed
    1. Tillett R.L., Sevinsky J.R., Hartley P.D., Kerwin H., Crawford N., Gorzalski A. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2021;21(1):52–58. doi: 10.1016/S1473-3099(20)30764-7. - DOI - PMC - PubMed
    2. Epub 2020 Oct 12. PMID: 33058797; PMCID: PMC7550103.